StockTipsArenaBeta

BUY MOLBIO DIAGNOSTICS LTD — Kotak Securities

BUYMOLBIO DIAGNOSTICS LTD
MOLBIO DIAGNOSTICS share price target & all analyst calls

byKotak SecuritiesHorizon: NA (inferred 1 year)13 Nov 2026via NDTV Profit

Entry₹1,412.6Inferred
Target₹1,700
Total upside +20.35%
Stop lossNot given
CMP₹1,493.21d ago
Active+5.71%+13.85%upside left 12 mo left
Follow Kotak Securities for new calls(92% target hit, 26 closed calls)Get alertsWatch MOLBIO for new buy/sell callsGet alertsSee 2 other Long-term calls on MOLBIOSee 272 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:24 am IST
12 supporting4 neutral2 opposing
Supports the BUY call (12)

2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·6 Nov · 1w ago

Neutral / worth noting (4)

Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·5 Nov · 1w ago

(opens in new tab)

Molbio Diagnostics Has Spare Capacity. Can It Turn That Into Growth?

NewsNdtv-Profit·22 Oct · 3w ago

(opens in new tab)
Weighs against the BUY call (2)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on MOLBIO DIAGNOSTICS

All analyst calls on MOLBIO DIAGNOSTICS

More from Kotak Securities

Every call and its outcome